Since launching its ambient medical transcription tool eight years ago, Abridge has set its sights on building a full-fledged AI…

Last year, Johnson & Johnson was a late entrant, announcing Imavi as the third FcRn blocker approved after 2021 to…

Recent research published in Pro Swan The study suggests that most Americans support government efforts to provide information about ultra-processed…

A healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s medicines framework and access…

Blood pressure management after thrombectomy for acute ischemic stroke may require a change in approach. HOPE clinical trial (abbreviation) Hemodynamic…